Vitrafy, Australia’s exciting new biotech company leading the way in innovative new patient orientated outcomes. Vitrafy is revolutionising the delivery of existing and emerging cell-based therapies from the research laboratory to the patient bedside. HOW WE DO IT: Cryopreservation plays a critical role in the biomedical life science industry. Current and emerging cellular therapies require successful cryopreservation of sensitive biological material that to-date, have had notoriously low and inconsistent success rates. Vitrafy have developed patented, cold chain solutions for the advancement in biomedical cryopreservation. These include a cryopreservation algorithm, freezing apparatus’, thawing apparatus’, tailored racking and packing solutions and a completely integrated software solution that includes data collection, reporting and processing automation.